Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

INM InMed Pharmaceuticals Inc

3,98

-0,24 (-5,69%)

28 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

InMed Pharmaceuticals (NASDAQ:INM)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more InMed Pharmaceuticals Charts.

InMed Pharmaceuticals (NASDAQ:INM)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more InMed Pharmaceuticals Charts.

News InMed Pharmaceuticals Inc

Form 8-K - Current report
Mittwoch 22 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 21 Januar 2025 (7 Tage vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 2 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 2 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Montag 30 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere InMed Pharmaceuticals Inc News-Artikel

Vontobel Financial Produ...

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen